Product Information

CARBATROL ER 300 MG CAPSULE is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $1.6955 per EA under NDC 54092017312. Its NADAC has been published 652 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the carbamazepine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CARBATROL ER 300 MG CAPSULE

carbamazepine
$1.6955per EA
High Outlier

Strength

300 mg/1

NDC

54092017312

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

CARBAMAZEPINE

Approval Type

New Drug (NDA)

FDA Application

NDA020712

On Market Since

9/30/1997

Pharmacological Classes

Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price Statistics

The NADAC for CARBATROL ER 300 MG CAPSULE has been published 652 times since Nov 28, 2013, and over the history we have for it it has declined 2.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.6955 per EA
All-time high$1.7457 (Feb 12, 2014)
All-time low$1.6867 (Feb 23, 2022)
52-week high$1.7013
52-week low$1.6955
Median price$1.7028
Average price$1.7046
Largest weekly change-2.0% (Feb 19, 2014)
Weeks tracked652
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-0.0%

3M

-0.1%

6M

-0.1%

1Y

-0.2%

3Y

+0.5%

5Y

+0.3%

All

-2.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the carbamazepine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of CARBATROL ER 300 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CARBATROL ER 300 MG CAPSULE, manufactured by Takeda Pharmaceuticals America, Inc., is $1.6955 per EA (NDC 54092017312), effective Jun 24, 2026.

How has the price of CARBATROL ER 300 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CARBATROL ER 300 MG CAPSULE has declined 2.9%. It has been tracked across 652 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CARBATROL ER 300 MG CAPSULE?

Since Nov 28, 2013, the NADAC for CARBATROL ER 300 MG CAPSULE has ranged from a low of $1.6867 (Feb 23, 2022) to a high of $1.7457 (Feb 12, 2014), with a median of $1.7028 per EA.

Are there cheaper alternatives to CARBATROL ER 300 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CARBATROL ER 300 MG CAPSULE, so no direct lower-cost alternative is listed.

Who manufactures CARBATROL ER 300 MG CAPSULE?

CARBATROL ER 300 MG CAPSULE (NDC 54092017312) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.